/

Developmental Biology

/

CRISPR/Cas9-Technologie zur Wiederherstellung der Dystrophinexpression in iPSC-abgeleiteten Muskelprogenitoren

JoVE Journal
Developmental Biology

A subscription to JoVE is required to view this content. Sign in or start your free trial.

JoVE Journal Developmental Biology

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Please note that all translations are automatically generated. Click here for the English version.

CRISPR/Cas9-Technologie zur Wiederherstellung der Dystrophinexpression in iPSC-abgeleiteten Muskelprogenitoren

8,148 Views

•

07:44 min

•

September 14, 2019

DOI:

10.3791/59432-v

DOI:

10.3791/59432-v

•

07:44 min

September 14, 2019

•

6 Views

Yue Jin, Yan Shen, Xuan Su, Neal Weintraub, Yaoliang Tang

¹Medical College of Georgia,Augusta University

Explore More Videos

CRISPR/Cas9 Dystrophin Duchenne Muscular Dystrophy Induced Pluripotent Stem Cells Muscle Progenitor Cells Gene Editing Stem Cell Therapy Autologous Cells Congenital Diseases

Read Article